Aldeyra Therapeutics, Inc.

NasdaqCM:ALDX Stock Report

Market Cap: US$283.2m

Aldeyra Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqCM:ALDX Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
12 Aug 24SellUS$51,313Bruce GreenbergIndividual10,834US$4.74
12 Aug 24SellUS$75,975Stephen MachathaIndividual16,041US$4.74
05 Apr 24BuyUS$833,867Perceptive Advisors LLCCompany177,993US$4.74
03 Apr 24BuyUS$1,934,505Perceptive Advisors LLCCompany504,272US$4.09
12 Mar 24SellUS$580,760Todd BradyIndividual183,238US$3.27
12 Mar 24SellUS$98,605Stephen MachathaIndividual29,768US$3.41
11 Mar 24SellUS$44,968Bruce GreenbergIndividual13,201US$3.41

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of ALDX?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders1,538,5712.58%
VC/PE Firms14,751,36724.8%
General Public21,187,49035.6%
Institutions22,072,17037.1%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 57.78% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
15.6%
Perceptive Advisors LLC
9,275,851US$44.1m0%1.06%
9.19%
Knoll Capital Management
5,475,516US$26.0m0%21.05%
6.32%
The Vanguard Group, Inc.
3,760,619US$17.9m0.49%no data
6.27%
BlackRock, Inc.
3,734,408US$17.8m3.1%no data
3.16%
Kennedy Capital Management LLC
1,881,078US$8.9m17.6%0.2%
1.94%
Todd Brady
1,155,580US$5.5m0%no data
1.87%
Geode Capital Management, LLC
1,114,628US$5.3m-2.06%no data
1.64%
State Street Global Advisors, Inc.
973,908US$4.6m1.69%no data
1.19%
Eagle Asset Management, Inc.
709,518US$3.4m-15.7%0.02%
1.07%
Invesco Capital Management LLC
638,446US$3.0m5,720%no data
1.01%
Dimensional Fund Advisors LP
604,041US$2.9m-10.1%no data
0.92%
Federated Hermes, Inc.
549,564US$2.6m3.45%0.01%
0.84%
Ardsley Advisory Partners LP
500,000US$2.4m0%0.45%
0.8%
Jacobs Levy Equity Management Inc
476,949US$2.3m163%0.01%
0.8%
Morgan Stanley, Investment Banking and Brokerage Investments
473,720US$2.3m83%no data
0.65%
Northern Trust Global Investments
388,623US$1.8m0.81%no data
0.65%
PFG Investments, LLC
386,447US$1.8m-2.47%0.12%
0.61%
Wells Fargo & Company, Securities and Brokerage Investments
364,202US$1.7m-2.62%no data
0.56%
D. E. Shaw & Co., L.P.
334,781US$1.6m3.99%no data
0.51%
ADAR1 Capital Management, LLC
302,212US$1.4m0%0.27%
0.5%
Deutsche Asset & Wealth Management
300,591US$1.4m0.08%no data
0.46%
Los Angeles Capital Management LLC
271,262US$1.3m-19%no data
0.43%
Bank of America Corporation, Asset Management Arm
258,726US$1.2m0.05%no data
0.43%
Acadian Asset Management LLC
254,314US$1.2m-43%no data
0.38%
Palo Alto Investors LP
225,465US$1.1m0%0.16%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 14:15
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Aldeyra Therapeutics, Inc. is covered by 22 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Raghuram SelvarajuAegis Capital Corporation
Keay NakaeAscendiant Capital Markets LLC
Esther Lannie HongBerenberg